Go Pro
→ Here’s Why Trump Won’t End The Iran War (From Banyan Hill Publishing) (Ad)tc pixel
LON:DXRX

Diaceutics Interim Earnings Report

Diaceutics logo
GBX 152 +7.00 (+4.83%)
As of 10:52 AM Eastern
ProfileEarnings HistoryForecast

Diaceutics EPS Results

Actual EPS
-GBX 2.84
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Diaceutics Announcement Details

Quarter
Interim
Date
9/23/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Diaceutics Earnings Headlines

Diaceutics boosts employee share incentives and updates total voting rights
August 4 at 9:10 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-boosts-employee-share-incentives-and-updates-total-voting-rights?utm_source=marketbeat.com&utm_medium=referral
Canaccord Genuity Group Reiterates "Buy" Rating for Diaceutics (LON:DXRX)
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931268
Real reason Trump banning Chinese models
President Trump's administration is drafting a ban on Chinese-made components used inside American AI data centers - not chips, but a small, overlooked part that moves data through every facility. The move stems from a new economic doctrine crafted by a controversial Silicon Valley CEO, one already reshaping which companies are considered safe investments. Analysts Porter Stansberry and Luke Lango break down the full story and the shifts investors should watch.tc pixel
August 6 at 1:00 AM  |  Porter & Company (Ad)
Diaceutics Issues Shares Under Employee Incentive Schemes in Latest Block Listing Update
April 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-shares-under-employee-incentive-schemes-in-latest-block-listing-update?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Executes Routine Management Share Purchases Under Incentive Plan With No Change to Share Capital
April 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-executes-routine-management-share-purchases-under-incentive-plan-with-no-change-to-share-capital?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Issues New Shares to Trust as PDMRs Participate in Incentive Plan
February 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-new-shares-to-trust-as-pdmrs-participate-in-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile
Earnings Tools